Ankylosing Spondylitis Market Size, Share & Trends Report

Ankylosing Spondylitis Market Size, Share & Trends Analysis Report By Drug (Cosentyx, Humira, Simponi, Remicade, Enbrel, Cimzia), By Region (North America, APAC, Europe, MEA), And Segment Forecasts, 2020 - 2027

Report ID: GVR-4-68038-728-5
Number of Pages: 185
Format: Electronic (PDF)

Historical Range: 2016 - 2018
Industry:Healthcare

Market Segmentation

Ankylosing SpondylitisDrug Outlook (Revenue, USD Million, 2016 - 2027)
- Cosentyx
- Humira
- Simponi
- Remicade
- Enbrel
- Cimzia
- Others
Ankylosing SpondylitisRegional Outlook (Revenue, USD Million, 2016 - 2027)
- North America
  - North America Ankylosing Spondylitis Market, by Drug
    - Cosentyx
    - Humira
    - Simponi
    - Remicade
    - Enbrel
    - Cimzia
    - Others
  - U.S.
    - U.S. Ankylosing Spondylitis Market, by Drug
      - Cosentyx
      - Humira
      - Simponi
      - Remicade
      - Enbrel
      - Cimzia
      - Others
  - Canada
    - Canada Ankylosing Spondylitis Market, by Drug
      - Cosentyx
      - Humira
      - Simponi
      - Remicade
      - Enbrel
      - Cimzia
      - Others
- Europe
  - Europe Ankylosing Spondylitis Market, by Drug
    - Cosentyx
    - Humira
    - Simponi
    - Remicade
    - Enbrel
    - Cimzia
    - Others
  - U.K.
    - U.K. Ankylosing Spondylitis Market, by Drug
      - Cosentyx
      - Humira
      - Simponi
      - Remicade
      - Enbrel
      - Cimzia
      - Others
  - Germany
    - Germany Ankylosing Spondylitis Market, by Drug
      - Cosentyx
      - Humira
      - Simponi
      - Remicade
      - Enbrel
      - Cimzia
      - Others
  - France
    - France Ankylosing Spondylitis Market, by Drug
      - Cosentyx
      - Humira
      - Simponi
      - Remicade
      - Enbrel
      - Cimzia
      - Others
  - Italy
    - Italy Ankylosing Spondylitis Market, by Drug
      - Cosentyx
      - Humira
      - Simponi
      - Remicade
      - Enbrel
      - Cimzia
      - Others
  - Spain
    - Spain Ankylosing Spondylitis Market, by Drug
      - Cosentyx
      - Humira
      - Simponi
      - Remicade
      - Enbrel
      - Cimzia
      - Others
- Asia Pacific
  - Asia Pacific Ankylosing Spondylitis Market, by Drug
    - Cosentyx
    - Humira
    - Simponi
    - Remicade
    - Enbrel
    - Cimzia
    - Others
  - Japan
    - Japan Ankylosing Spondylitis Market, by Drug
      - Cosentyx
      - Humira
      - Simponi
      - Remicade
      - Enbrel
      - Cimzia
      - Others
  - China
    - China Ankylosing Spondylitis Market, by Drug
      - Cosentyx
      - Humira
      - Simponi
      - Remicade
      - Enbrel
      - Cimzia
      - Others
  - India
    - India Ankylosing Spondylitis Market, by Drug
      - Cosentyx
      - Humira
      - Simponi
      - Remicade
      - Enbrel
      - Cimzia
      - Others
  - Australia
    - Australia Ankylosing Spondylitis Market, by Drug
      - Cosentyx
      - Humira
      - Simponi
      - Remicade
      - Enbrel
      - Cimzia
      - Others
  - South Korea
    - South Korea Ankylosing Spondylitis Market, by Drug
      - Cosentyx
      - Humira
      - Simponi
      - Remicade
      - Enbrel
      - Cimzia
      - Others
- Latin America
  - Latin America Ankylosing Spondylitis Market, by Drug
    - Cosentyx
    - Humira
    - Simponi
    - Remicade
    - Enbrel
    - Cimzia
    - Others
  - Brazil
    - Brazil Ankylosing Spondylitis Market, by Drug
      - Cosentyx
      - Humira
      - Simponi
      - Remicade
      - Enbrel
      - Cimzia
      - Others
  - Mexico
    - Mexico Ankylosing Spondylitis Market, by Drug
      - Cosentyx
      - Humira
      - Simponi
      - Remicade
      - Enbrel
      - Cimzia
      - Others
  - Chile
    - Chile Ankylosing Spondylitis Market, by Drug
      - Cosentyx
      - Humira
      - Simponi
      - Remicade
      - Enbrel
      - Cimzia
      - Others
  - Columbia
    - Columbia Ankylosing Spondylitis Market, by Drug
      - Cosentyx
      - Humira
      - Simponi
      - Remicade
      - Enbrel
      - Cimzia
      - Others
  - Argentina
    - Argentina Ankylosing Spondylitis Market, by Drug
      - Cosentyx
      - Humira
      - Simponi
      - Remicade
      - Enbrel
      - Cimzia
      - Others
- Middle East & Africa
  - Middle East & Africa Ankylosing Spondylitis Market, by Drug
    - Cosentyx
    - Humira
    - Simponi
    - Remicade
    - Enbrel
    - Cimzia
    - Others
  - South Africa
    - South Africa Ankylosing Spondylitis Market, by Drug
      - Cosentyx
      - Humira
      - Simponi
      - Remicade
      - Enbrel
      - Cimzia
      - Others
  - Saudi Arabia
    - Saudi Arabia Ankylosing Spondylitis Market, by Drug
      - Cosentyx
      - Humira
      - Simponi
      - Remicade
      - Enbrel
      - Cimzia
      - Others
  - UAE
    - UAE Ankylosing Spondylitis Market, by Drug
      - Cosentyx
      - Humira
      - Simponi
      - Remicade
      - Enbrel
      - Cimzia
      - Others

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
乐鱼体育手机网站入口
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments

Quantitative Analysis

Market size, estimates, and forecast from 2016 to 2027
Market estimates and forecast for product segments up to 2027
Regional market size and forecast for product segments up to 2027
Market estimates and forecast for application segments up to 2027
Regional market size and forecast for application segments up to 2027
Company financial performance

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report -free of charge- including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

Leading SME award by D&B

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read ourprivacy policy.